This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
European Journal of Heart Failure
JANUARY 17, 2025
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end-organ dysfunction.
American College of Cardiology
MARCH 30, 2025
Implantation of an intra-aortic balloon pump (IABP) did not improve 60-day survival or bridge to heart replacement (HRT) therapies in patients with heart failure-cardiogenic shock (HF-CS) compared to standard care, according to a study presented during a Featured Clinical Research session at ACC.25
American College of Cardiology
MARCH 18, 2025
A simplified risk stratification model based on the cardiogenic shock (CS) classification system from the Society for Cardiovascular Angiography and Intervention (SCAI) effectively predicts in-hospital mortality in postcardiotomy (PC) patients, according to a retrospective, observational study.
American College of Cardiology
APRIL 7, 2024
The goal of the DanGer Shock trial was to compare the safety and efficacy of Impella CP on top of standard care compared with standard care alone among patients with ST-segment elevation myocardial infarction (STEMI) and cardiogenic shock.
American College of Cardiology
MARCH 17, 2025
The ACC has released its first Concise Clinical Guidance focused on best practices for the evaluation and management of patients with cardiogenic shock (CS).
American College of Cardiology
FEBRUARY 1, 2024
What are the characteristics and outcomes of cardiogenic shock (CS) in children hospitalized for acute decompensated heart failure (ADHF)?
American College of Cardiology
APRIL 7, 2024
Implantation of the Impella CP micro-axial flow pump may increase survival at six months among patients with STEMI complicated by cardiogenic shock (CS), according to the results of the DanGer Shock study.
American College of Cardiology
SEPTEMBER 13, 2024
The goal of the ECLS-SHOCK trial was to evaluate extracorporeal life support (ECLS) compared with control among patients with acute myocardial infarction (MI) and cardiogenic shock.
Circulation: Heart Failure
MARCH 28, 2025
Cardiogenic shock (CS) remains a significant challenge in cardiovascular medicine, characterized by substantial morbidity and mortality. This article delves into the evolution, current implementations, and future directions of CS teams, emphasizing their crucial role in enhancing patient outcomes.
American College of Cardiology
SEPTEMBER 11, 2024
In this week’s View, Dr. Eagle looks at temporary mechanical circulatory support in infarct-related cardiogenic shock.
American College of Cardiology
MARCH 26, 2025
In this weeks View, Dr. Eagle looks at the latest clinical guidance on the management of cardiogenic shock.
American College of Cardiology
MARCH 12, 2024
The following are key points to remember from an American Heart Association Scientific Statement on cardiogenic shock (CS) in older adults, which focuses on age-associated risks and approach to management.
American College of Cardiology
AUGUST 31, 2024
Most of the change in stage of cardiogenic shock (CS) occurred within the first 24 hours of presentation, with little change thereafter, according to a study by the Cardiogenic Shock Working Group (CSWG) presented at ESC Congress 2024 in London and simultaneously published in JACC.
European Journal of Heart Failure
DECEMBER 19, 2024
Ventilatory modalities in cardiogenic shock: insights from the AltShock-2 registry. Aims To describe the use and the relation to outcome of different ventilation strategies in a contemporary, large, prospective registry of cardiogenic shock patients.
European Journal of Heart Failure
DECEMBER 11, 2024
In acute heart failure caused by VHD, symptoms result from rapid haemodynamic changes and subsequent decline in cardiac function, and if left untreated, leads to acute decompensation and cardiogenic shock. After screening a total of 2234 articles, 76 published between 1994 and 2023 were included in subsequent analysis.
European Journal of Heart Failure
DECEMBER 13, 2023
Impella and venoarterial extracorporeal membrane oxygenation (VA-ECMO) in patients with acute myocardial infarction-related cardiogenic shock (AMICS). Methods and results This nationwide observational cohort study describes all AMICS patients treated with Impella (ABIOMED, Danvers, MA, USA) and/or VA-ECMO in 2020–2021.
European Journal of Heart Failure
NOVEMBER 23, 2023
Clinical presentation, shock severity and mortality in patients with de novo versus acute-on-chronic heart failure-related cardiogenic shock. ACHF-CS, acute-on-chronic failure-related cardiogenic shock; CI, confidence interval; DNHF-CS, de novo heart failure-related cardiogenic shock; HR, hazard ratio.
American College of Cardiology
MARCH 31, 2025
The goal of the Altshock-2 trial was to evaluate the effect of early intra-aortic balloon pump (IABP) use vs. standard care on 60-day survival or successful bridging to heart replacement therapies (HRT) in patients with heart failurecardiogenic shock (HF-CS).
Circulation: Heart Failure
JANUARY 20, 2025
Circulation: Heart Failure, Ahead of Print.
Frontiers in Cardiovascular Medicine
MARCH 10, 2024
Methods We conducted a comprehensive search for articles on PubMed and Embase using search strategies which yielded 4,061 articles. After full-text screening, 66 articles were included for systematic review, and 62 articles were further selected for meta-analysis. 1.77), cardiogenic shock (pooled RR 3.68, 95% CI 2.65–5.11),
American College of Cardiology
AUGUST 28, 2024
Randomized trials of patients in cardiogenic shock (CS) have been challenging to conduct. The DanGer Shock (Microaxial Flow Pump in Infarct-Related Cardiogenic Shock) trial was an important study in this space that was successfully concluded after 10 years because of slow recruitment.
American College of Cardiology
SEPTEMBER 9, 2024
What is the effect of early routine active percutaneous mechanical circulatory support (MCS) versus control treatment on 6-month all-cause mortality in patients with acute myocardial infarction-related cardiogenic shock (AMICS)?
American College of Cardiology
NOVEMBER 18, 2024
Older patients with STEMI-related cardiogenic shock have a greater risk of mortality and may not experience the same benefit from microaxial flow pump (mAFP) treatment as their younger counterparts, according to an exploratory secondary analysis of the DanGer Shock trial presented at AHA 2024 and simultaneously published in JACC.
Dr. Smith's ECG Blog
OCTOBER 8, 2024
A temporary pacemaker was implanted, and she was admitted to the ICU with cardiogenic shock. HYPERACUTE T-WAVES ARE EASILY RECOGNIZED BY THE QUEEN OF HEARTS HYPERACUTE T-WAVES DO NOT EVOLVE INTO ST ELEVATION -- THIS IS A MYTH Pendell and I are about to submit an article on ECG findings in total 100% LAD Occlusion (LAD OMI).
122 European Journal of Heart Failure
JANUARY 14, 2025
PMR patients were more likely to present in cardiogenic shock (91% vs. 51%, p =0.001), require mechanical circulatory support (74% vs. 34%, p =0.01), and had a higher EuroSCORE II (2313% vs. 1311%, p =0.011). Aetiology of MR, cardiogenic shock, and procedure timing significantly impacted in-hospital mortality.
Circulation
NOVEMBER 11, 2024
The chapters included a topic overview with key learning points, a case presentation, review questions, attending pearls, and high-yield articles for further reading. Topics included management of arrhythmias, structural heart disease, ischemia, cardiogenic shock, and post-procedure complications.
Dr. Smith's ECG Blog
NOVEMBER 19, 2016
Authors' commentary: Cardiogenic shock in the setting of severe aortic stenosis. This patient’s severe aortic stenosis (AS) and associated severe cardiogenic shock likely created the ECG pattern, resulting in a very difficult challenge for our inpatient team. If you can use Doppler, then you can diagnose it.
40 
The British Journal of Cardiology
APRIL 16, 2024
Clinical presentation was stable angina 130/567 (22.9%), non-ST-elevation acute coronary syndrome (NSTEACS) 312/567 (55%), ST-elevation myocardial infarction (STEMI) 125/567 (22.0%), and STEMI with cardiogenic shock 13/125 (10.4%). The radial approach was used in 544/567 (95.94%), the average SYNTAX score was 34.8 ± 9.6,
40 European Journal of Heart Failure
FEBRUARY 16, 2025
Organ perfusion pressure as a predictor of outcomes in cardiogenic shock: insights from the Altshock-2 registry. ABSTRACT Aims The diagnosis of cardiogenic shock (CS) relies upon signs and/or symptoms of end-organ hypoperfusion.
Dr. Smith's ECG Blog
MARCH 12, 2018
When there is tachycardia, the patient is in cardiogenic shock with very poor LV function on bedside echo. We hope you can see the difference: See these cases for more examples: Syncope, Shock, AV block, Large RV, "Anterior" ST Elevation. In this case we have a crashing patient while T-wave inversion is ongoing! Kosuge et al.
40 
Dr. Smith's ECG Blog
FEBRUARY 28, 2020
In the Marchik article, (assuming they defined it the same way, and the methods do not specify this), among patients with suspicion for PE, S1Q3T3 was found in 8.5% In the Marchik article, (assuming they defined it the same way, and the methods do not specify this), among patients with suspicion for PE, S1Q3T3 was found in 8.5%
52 
European Journal of Heart Failure
FEBRUARY 23, 2024
Cardiogenic shock is a primary cardiac disorder that results in both clinical and biochemical evidence of tissue hypoperfusion and can lead to multi-organ failure and death depending on its severity. Despite some advances in cardiogenic shock management, this clinical syndrome is still burdened by an extremely high mortality.
American College of Cardiology
JUNE 25, 2024
Cardiogenic shock is a common complication in patients who present with acute myocardial infarction (AMI) and is the leading cause of death in this population. Even with immediate revascularization, death rates remain high.
European Journal of Heart Failure
JANUARY 17, 2025
Predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in patients with cardiogenic shock. RRT, renal replacement therapy. interquartile range 4.112.7] mmol/L).
European Journal of Heart Failure
FEBRUARY 5, 2025
Aims Among patients with cardiogenic shock, immediate initiation of extracorporeal membrane oxygenation (ECMO) did not demonstrate any benefit at 30days. The present study evaluated 1-year clinical outcomes of the Extracorporeal Membrane Oxygenation in the therapy of Cardiogenic Shock (ECMO-CS) trial.
European Journal of Heart Failure
DECEMBER 12, 2023
Abstract Objectives This study aimed to assess the impact of anemia and iron deficiency (ID) on clinical outcome in patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI).
Dr. Smith's ECG Blog
JULY 21, 2024
The patient in today’s case presented in cardiogenic shock from proximal LAD occlusion, in conjunction with a subtotally stenosed LMCA. baseline (this is what most recommend but seems like far too much QRS widening to me) = See these articles and this graphic: 1. LAD — 100% proximal occlusion; with 70-89% mid-vessel narrowing.
130 
Ken Grauer, MD
OCTOBER 25, 2024
Figure-3: The 2 ECG Patterns of Wellens' Syndrome — as reported in the original 1982 article ( Figure adapted from de Zwaan, Bär & Wellens: Am Heart J 103:730-736, 1982 ). Unfortunately — this patient died within 12 hours of obtaining this tracing from cardiogenic shock.
94 
Dr. Smith's ECG Blog
NOVEMBER 12, 2020
Assessment was severe sudden cardiogenic shock. 4 Unfortunately, this article provides no electrocardiographic, echo, or angiographic data, so it is not certain that these high levels were in the absence of acute MI. Clinically — the patient was felt to be in cardiogenic shock. What is it? There is STE in V2-V6.
Dr. Smith's ECG Blog
OCTOBER 7, 2019
Why is the patient in shock? He was in profound cardiogenic shock. Here is full text of this article. There is an obvious inferior STEMI, but what else? Besides the obvious inferior STEMI, there is across the precordial leads also, especially in V1. This STE is diagnostic of Right Ventricular STEMI (RV MI).
40 
Dr. Smith's ECG Blog
AUGUST 9, 2019
At the bottom of the post, I have re-printed the section on aVR in my article on the ECG in ACS from the Canadian Journal of Cardiology: New Insights Into the Use of the 12-Lead Electrocardiogram for Diagnosing Acute Myocardial Infarction in the Emergency Department Case 1. Of those who do get to the ED, many present with clear STE.(65,
Dr. Smith's ECG Blog
JANUARY 15, 2024
Tachycardia is unusual for OMI, unless the patient is in cardiogenic shock (or getting close). The September 27, 2019 post — for the Rowlands & Moore article with the above-noted formulas for recognizing the “culprit” extremity. We can see enough to make out that the rhythm is sinus tachycardia.
63 
European Journal of Heart Failure
FEBRUARY 5, 2025
Risk prediction for cardiogenic shock patients with Impella. Abstract Aims Impella has become a new option for mechanical circulatory support in patients with cardiogenic shock (CS); however, prognostic models for patients after Impella are lacking.
European Journal of Heart Failure
FEBRUARY 5, 2025
Timing of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support in patients with cardiogenic shock. Abstract Aims The optimal timing for implementing mechanical circulatory support (MCS) in cardiogenic shock (CS) remains indeterminate.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content